These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 23928024

  • 1. Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase.
    Chen Q, Li X, Zhou H, Jiang Y, Chen Y, Hua X, Yu Y.
    J Antimicrob Chemother; 2014 Jan; 69(1):72-6. PubMed ID: 23928024
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
    Peleg AY, Adams J, Paterson DL.
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2065-9. PubMed ID: 17420217
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism.
    Trebosc V, Gartenmann S, Royet K, Manfredi P, Tötzl M, Schellhorn B, Pieren M, Tigges M, Lociuro S, Sennhenn PC, Gitzinger M, Bumann D, Kemmer C.
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7263-7271. PubMed ID: 27671072
    [Abstract] [Full Text] [Related]

  • 7. AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii.
    Hornsey M, Ellington MJ, Doumith M, Thomas CP, Gordon NC, Wareham DW, Quinn J, Lolans K, Livermore DM, Woodford N.
    J Antimicrob Chemother; 2010 Aug; 65(8):1589-93. PubMed ID: 20554571
    [Abstract] [Full Text] [Related]

  • 8. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Navon-Venezia S, Leavitt A, Carmeli Y.
    J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.
    Tiengrim S, Tribuddharat C, Thamlikitkul V.
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251
    [Abstract] [Full Text] [Related]

  • 15. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report.
    Peleg AY, Potoski BA, Rea R, Adams J, Sethi J, Capitano B, Husain S, Kwak EJ, Bhat SV, Paterson DL.
    J Antimicrob Chemother; 2007 Jan; 59(1):128-31. PubMed ID: 17082201
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of insertion sequence Aba-1 and AdeS in reduced tigecycline susceptibility in MDR-Acinetobacter baumannii clinical isolates from Cairo, Egypt.
    Hassan R, Mukhtar A, Hasanin A, Ghaith D.
    J Chemother; 2018 Apr; 30(2):89-94. PubMed ID: 29108486
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.